KEYTRUDA QLEX
NDC 0006-3083 · Merck Sharp & Dohme LLC
Generic namepembrolizumab and berahyaluronidase alfa-pmph
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)PEMBROLIZUMAB, BERAHYALURONIDASE ALFA
Strength2000; 165 U/mL; mg/mL
Pharmacologic classEndoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Marketing categoryBLA
Packages
0006-3083-01 — 1 VIAL in 1 CARTON (0006-3083-01) / 2.4 mL in 1 VIAL (0006-3083-99)
Billed under HCPCS
J9277 — Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph Medicare Part B payment limit (ASP + 6%): $31.94
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0006-3026 — pembrolizumab, 0006-5083 — pembrolizumab and berahyaluronidase alfa-pmph